These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2869676)

  • 1. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
    Singh BN; Rebanal P; Piontek M; Nademanee K
    Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
    Subramanian VB; Bowles MJ; Davies AB; Raftery EB
    Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of verapamil and beta blockers in systemic hypertension.
    Dargie H; Cleland J; Findlay I; Murray G; McInnes G
    Am J Cardiol; 1986 Feb; 57(7):80D-82D. PubMed ID: 3513518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of beta-adrenoceptor blockers and calcium antagonists in hypertension.
    Doyle AE
    Hypertension; 1983; 5(4 Pt 2):II103-8. PubMed ID: 6134671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study.
    Johnston DL; Lesoway R; Humen DP; Kostuk WJ
    Am J Cardiol; 1985 Mar; 55(6):680-7. PubMed ID: 3883739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil compared with nifedipine in the treatment of essential hypertension.
    Midtbø K; Hals O; van der Meer J
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S363-8. PubMed ID: 6184569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of verapamil and propranolol on exercise tolerance in hypertensive patients.
    Mooy J; van Baak M; Böhm R; Does R; Petri H; van Kemenade J; Rahn KH
    Clin Pharmacol Ther; 1987 May; 41(5):490-5. PubMed ID: 3552358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verapamil and propranolol in essential hypertension.
    Halperin AK; Gross KM; Rogers JF; Cubeddu LX
    Clin Pharmacol Ther; 1984 Dec; 36(6):750-8. PubMed ID: 6499355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.
    Lefrandt JD; Heitmann J; Sevre K; Castellano M; Hausberg M; Fallon M; Urbigkeit A; Rostrup M; Agabiti-Rosei E; Rahn KH; Murphy M; Zannad F; de Kam PJ; Smit AJ
    Br J Clin Pharmacol; 2001 Dec; 52(6):687-92. PubMed ID: 11736880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amlodipine and verapamil in the treatment of mild to moderate hypertension.
    Lorimer AR; Smedsrud T; Walker P; Tyler HM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S89-93. PubMed ID: 2467138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of calcium-channel blockers and beta-blockers in essential hypertension: clinical implications.
    Massie BM; Tubau JF; Szlachcic J
    Circulation; 1987 Jun; 75(6 Pt 2):V163-9. PubMed ID: 2882873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
    McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic blockade compared with beta-adrenergic blockade in systemic hypertension: a double-blind comparison of ketanserin with propranolol.
    Okin S; Huberfeld SI; Frishman WH; Soberman J; Laifer L; Greenberg S; Lapsker J; Charlap S; Strom JA
    J Clin Pharmacol; 1988 Nov; 28(11):1008-16. PubMed ID: 2907519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between two calcium antagonists and two beta blockers in conscious rabbits: hemodynamic consequences of differing cardiodepressant properties.
    Hof RP
    Am J Cardiol; 1987 Jan; 59(3):43B-51B. PubMed ID: 2880495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic effects during rest and exercise of bucindolol in hypertensive men.
    Conner DP; Vlasses PH; Clementi RA; Oren A; Deitchman D; Ferguson RK
    J Clin Pharmacol; 1987 Apr; 27(4):300-3. PubMed ID: 2890669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.